Peninsula Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,716
Closed -$257K 99
2024
Q2
$257K Buy
+1,716
New +$255K 0.05% 86
2024
Q1
Sell
-1,334
Closed -$209K 95
2023
Q4
$209K Sell
1,334
-824
-38% -$126K 0.04% 83
2023
Q3
$327K Buy
2,158
+151
+8% +$24.9K 0.08% 63
2023
Q2
$332K Hold
2,007
0.09% 59
2023
Q1
$311K Sell
2,007
-250
-11% -$40.4K 0.09% 57
2022
Q4
$399K Buy
2,257
+84
+4% +$14.5K 0.13% 44
2022
Q3
$355K Buy
2,173
+98
+5% +$16.6K 0.13% 43
2022
Q2
$368K Buy
2,075
+57
+3% +$10.2K 0.12% 42
2022
Q1
$358K Buy
2,018
+63
+3% +$10.7K 0.1% 45
2021
Q4
$334K Buy
+1,955
New +$320K 0.09% 51

Other funds holding JNJ

Peninsula Wealth's JNJ Position: Q3 2024 in Review

Peninsula Wealth sold out of Johnson & Johnson (JNJ) in Q3 2024, closing a stake of 1,716 shares — an estimated $257K sold.

Peninsula Wealth first reported a position in JNJ in Q4 2021 and held it in 10 quarters. The position peaked at $399K in Q4 2022. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Peninsula Wealth reported no remaining Johnson & Johnson position as of Q3 2024 after selling out during the quarter.
  • Peninsula Wealth sold 1,716 Johnson & Johnson shares in Q3 2024, an estimated $257K.
  • Peninsula Wealth first reported a position in Johnson & Johnson in Q4 2021 and held it in 10 quarters.
  • Peninsula Wealth's Johnson & Johnson position peaked at $399K in Q4 2022.
  • 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Peninsula Wealth's 13F filing for Q3 2024, filed 14 Nov 2024.